Skip to content
FrontierPicks

Dormant

GSHD · Goosehead Insurance, Inc.

Last analysed ·

Current thesis

Goosehead Insurance’s recovery case requires renewed core-revenue growth and a weekly reclaim of $64 after the September 18 structural failure. Q3 core growth above 10% would confirm the operating leg; a weekly close below $54.28 would defeat the recovery hypothesis.

Kill line

A weekly close below $54.28 ends the recovery hypothesis by breaking the July 17, 2026 reference close; a reduction in the July 22 outlook for 12–19% annual organic revenue growth would independently undermine the operating case.

Pick status

Open commitment scored if the kill line above fires How this is scored →

Latest analysis and events for GSHD —

As of 19 September 2026, the latest FrontierPicks analysis for Goosehead Insurance, Inc. (GSHD): Goosehead Insurance’s recovery case requires renewed core-revenue growth and a weekly reclaim of $64 after the September 18 structural failure. Q3 core growth above 10% would confirm the operating leg; a weekly close below $54.28 would defeat the recovery hypothesis.

Kill line: A weekly close below $54.28 ends the recovery hypothesis by breaking the July 17, 2026 reference close; a reduction in the July 22 outlook for 12–19% annual organic revenue growth would independently undermine the operating case.

Current Thesis

Goosehead Insurance’s recovery case requires renewed core-revenue growth and a weekly reclaim of $64; a weekly close below $54.28 would defeat that recovery hypothesis. The September 18, 2026 adjusted close of $54.55 has already breached the previous dossier’s $64 weekly invalidation condition. The earlier thesis has failed; the recovery case is a separate, low-conviction proposition.

The post-earnings narrative is dead — the September 18 close broke the structure identified in the September 5 note and returned price near the July 17 reference close of $54.28. That classification is an inference from the observed price failure, not a finding that Goosehead’s business has stopped growing. A recovery would require both a weekly close above $64 and third-quarter core-revenue growth above the 10% reported on July 22, before the new invalidation condition occurs.

Bullish and bearish views on Goosehead Insurance, Inc.

The model's bull view on Goosehead Insurance, Inc. (GSHD), in brief: The operating business still grew. Goosehead’s July 22, 2026 results reported second-quarter core revenue of $95.6 million, up 10% year over year. This supplies an operating foundation for the recovery hypothesis, although it does not establish acceleration. Company results The… The bear view: Commission mix complicates the beat. The July 22, 2026 release showed total revenue growth of 21%, versus core growth of 10%. Company results The prior structure has failed. The September 18, 2026 reference close of $54.55 is below the $64 condition published on September 5. The… Both cases follow in full.

Bull Case

  • The operating business still grew. Goosehead’s July 22, 2026 results reported second-quarter core revenue of $95.6 million, up 10% year over year. This supplies an operating foundation for the recovery hypothesis, although it does not establish acceleration. Company results
  • The annual outlook improved. On July 22, management raised the floor of its 2026 organic total-revenue growth outlook to 12%, retaining the 19% ceiling. A subsequent reduction would contradict this part of the recovery case. Company results
  • Policy growth supports continuing demand. Policies in force grew 15% year over year at June 30, 2026, according to the July 22 release. That measured expansion supports the business-growth argument; it does not establish that the September price decline has ended. Company results

Bear Case

  • Commission mix complicates the beat. The July 22, 2026 release showed total revenue growth of 21%, versus core growth of 10%. Company results
  • The prior structure has failed. The September 18, 2026 reference close of $54.55 is below the $64 condition published on September 5. The failure is observable without attributing the decline to an unverified news event.
  • Insider supply accompanied the advance. Serena Jones’s Form 4, signed August 21, 2026, reported sales of 29,750 Class A shares on August 19–20 at $67.56–$70.15. Those transactions establish selling during the August advance; they do not establish what caused the subsequent decline.

Setup & Price Structure

The supplied adjusted daily series places the September 18, 2026 close at $54.55. The relevant historical references are the July 17 close of $54.28 and the $64 shelf identified in the September 5 dossier. The latter has become a recovery hurdle after its failure.

The 14-period relative strength index was 18.9 on September 18. That is a measured momentum reading; this single observation does not support a claim that a bottom has formed. Moving-average values and participation data are missing, so neither distance above a rising average nor widening demand can be established.

The August 19–20 insider transactions provide a concrete supply observation. The available evidence does not establish broad retail crowding, and isolated coverage items cannot support that conclusion. Benzinga’s analyst-action table, checked September 19, still lists July 27 as its latest dated target change; that table provides no fresh September revision supporting a recovery. Analyst-action record

Catalyst Calendar (next 30 days)

For September 19–October 19, 2026, no company-confirmed catalyst was identified in the available investor-relations calendar. The calendar lists the July 22 results call among past events but does not establish a third-quarter reporting date. Company events

  • ~2026-10-28, estimated: third-quarter results. MarketBeat estimates October 28 as of September 19 and explicitly says the company has not confirmed the date. This supersedes the earlier dossier’s October 21 estimate as the working calendar reference, without treating either as company guidance. The report tests whether core-revenue growth exceeds the second quarter’s 10% and whether the raised annual outlook survives. Earnings calendar

What Would Change Our Mind

Failure of the July reference area would end the residual recovery hypothesis: a weekly close below $54.28 would break the July 17, 2026 reference close. This condition does not reverse or erase the earlier $64 invalidation, which the September 18 close has already satisfied.

The recovery case would be established only by both a weekly close above the former $64 shelf and third-quarter core-revenue growth above the 10% reported on July 22, before the new price condition fires. A reduction in the July 22 annual organic-growth outlook would independently undermine the operating argument. A price rebound alone would leave that argument unresolved.

Correlation Notes

This is a single-name setup. No matched return series is available to establish a measured relationship with housing equities, insurance peers or small-cap indexes as of September 18, 2026. The earlier dossier’s sector tags therefore provide no evidence that a group move can repair the broken price structure.

The July 22 results identify contingent commissions as a distinct revenue contributor. Carrier profitability is consequently a business sensitivity, but the available observations do not establish a stock-price correlation with catastrophe losses or weather events.

Notes

  • Up-C structure: consolidated net income differs from the amount attributable to Goosehead Insurance, Inc. Read the attributable line, not the headline.
  • Class A/Class B structure: founder-side supply arrives via LLC-unit and Class B conversions into Class A, so it never appears as open-market purchase history.
  • Contingent commissions are lumpy and carrier-profitability dependent — $15.7M in Q2 2026 versus $4.5M a year earlier. Quarter-over-quarter revenue comparisons need this line stripped out.
  • Sell-side dispersion is wide for a name at this scale: one aggregator shows a $43–$125 range across 17 analysts, split 6 Buy / 6 Hold / 1 Sell.
  • The Q3 2026 earnings date was still unannounced as of 2026-09-05; the ~2026-10-21 reference is an estimate from the 2026-04-22 and 2026-07-22 print dates.

Related · shared themes

See also · stocks to watch